The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
JPMorgan Healthcare Leaders ETF · Issued by JPMorgan
| ABBV | AbbVie Inc | 7.94% |
| LLY | Eli Lilly and Co | 7.58% |
| MRK | Merck & Co Inc | 5.31% |
| JNJ | Johnson & Johnson | 4.85% |
| TMO | Thermo Fisher Scientific Inc | 4.11% |
| UNH | UnitedHealth Group Inc | 3.63% |
| BMY | Bristol-Myers Squibb Co | 3.55% |
| AZN.L | AstraZeneca PLC | 3.46% |
| ABT | Abbott Laboratories | 3.15% |
| NOVO-B.CO | Novo Nordisk AS Class B | 2.92% |
No recent news for JDOC. The ingest cron pulls every 15 minutes during market hours.